Lipogenesis and the Pentose Phosphate Pathway

Lipogenesis: Concepts and Locations

  • Definition: Lipogenesis is the synthesis of fatty acids from acetyl−CoAacetyl-CoA.
  • Substrate Origin: While acetyl−CoAacetyl-CoA can be derived from various sources, it mainly comes from glucose in this context, as insulin is the primary stimulant for this pathway.
  • Distinction from Esterification:
    • Lipogenesis refers specifically to the creation of the fatty acid chain.
    • Esterification is the subsequent formation of the triglyceride (triacylglycerol/fat) using glycerol−3−phosphateglycerol-3-phosphate.
  • Chemical Reductant Requirements: Synthesis requires a source of reductant to transition from a −CHOH−-CHOH- group to a −CH2−CH2−-CH_2-CH_2- group.
  • Tissue Specificity:
    • Adipose Tissue (White Adipose Tissue/WAT): Regarded as the "GOOD" place for fat storage.
    • Liver: Regarded as the "BAD" place for fat accumulation.

Metabolic Overview: The Glucose-Lipogenesis Connection

  • The Pathway Flow:
    • Glucose enters via GLUT−4GLUT-4 and is phosphorylated to G6PG6P (Glucose-6-phosphate) by HKHK (Hexokinase).
    • Glycolysis converts G6PG6P to pyruvatepyruvate; NADHNADH produced here provides ATPATP via the electron transport chain.
    • PyruvatePyruvate enters the mitochondria and is converted to acetyl−CoAacetyl-CoA by PDHPDH (Pyruvate Dehydrogenase).
    • Acetyl−CoAAcetyl-CoA must be transported out of the mitochondria into the cytosol using a specialized system (Citrate Transport).
    • Once in the cytosol, lipogenesis consumes reductant (NADPHNADPH) and ATPATP to produce fatty acids.
    • Fatty acids are then combined with glycerol−3−Pglycerol-3-P via esterification to form Fat.
  • Key Biological Tensions: There is a natural tension between glycogen synthesis (GSGS) and lipogenesis regarding glucose disposal.
  • Location Note: Lipogenesis is a wholly cytosolic process.

Acetyl-CoA Carboxylase (ACC): The Regulatory Gateway

  • Function: ACC activates or "primes" acetyl−CoAacetyl-CoA for lipogenesis by converting it into malonyl−CoAmalonyl-CoA.
  • Chemical Reaction:
    • It is a carboxylation reaction that adds carbon dioxide (derived from bicarbonate) to acetyl−CoAacetyl-CoA.
    • Equation: Acetyl−CoA+HCO3−→malonyl−CoAAcetyl-CoA + HCO_3^- \rightarrow malonyl-CoA.
    • This reaction requires energy input: ATP→ADP+PiATP \rightarrow ADP + P_i.
  • Cofactor: Biotin is involved in this reaction, consistent with its role in other carboxylation reactions.
  • Regulatory Factors:
    • Insulin: Stimulates ACC via dephosphorylation by phosphatases.
    • Citrate: Allosterically stimulates ACC. High levels of citrate cause ACC molecules to form a "weirdly active chain" or polymer.
    • Long-chain fatty acyl-CoA: Inhibits ACC allosterically (feedback inhibition by the ultimate product of the fatty acid synthesis pathway).

Fatty Acid Synthase (FAS): The Multi-Functional Reaction Complex

  • Structure: FAS is described as a "massive multifunctional protein" with numerous catalytic sites.
  • Catalytic Capabilities: The enzyme is responsible for:
    1. Bringing in acetylacetyl and malonylmalonyl groups.
    2. Decarboxylating the malonylmalonyl group.
    3. Catalyzing the reaction between the decarboxylated malonylmalonyl and the growing fatty acid chain.
    4. The reduction-dehydration-reduction steps.
    5. Translocating the growing fatty acid to the correct site for the next cycle.
    6. Releasing the finished chain as FA−CoAFA-CoA.

Mechanisms of Chain Growth and Comparison to Beta-Oxidation

  • Synthesis Cycle (Lipogenesis):
    • Chain growth occurs 2C2C (two carbons) at a time.
    • Sequence: Reduction →\rightarrow Dehydration →\rightarrow Reduction.
    • Mechanism involves highly activated acetate left after decarboxylation.
    • There is tight covalent binding between substrates and the enzyme.
    • FAS has two primary sites: one for the malonylmalonyl and active acetateacetate group, and one for the growing chain.
  • Degradation Cycle (Beta-Oxidation):
    • Chain cutting occurs 2C2C at a time.
    • Sequence: Oxidation →\rightarrow Hydration →\rightarrow Oxidation.
  • Reductant Use: FAS utilizes NADPHNADPH to convert a C=OC=O (carbonyl) to CHOHCHOH (hydroxyl), and used again to convert −CH=CH−-CH=CH- to −CH2−CH2−-CH_2-CH_2- (alkane).

Inputs, Outputs, and Desaturation Limits

  • Requirements per 2C addition:
    • 22 molecules of NADPHNADPH are required.
    • NO ATP is consumed during the actual cycle on the FAS complex (energy was invested at the ACC step).
    • Carbon dioxide is released (the same CO2CO_2 added during the production of malonyl−CoAmalonyl-CoA).
    • Note: The carboxylation of acetyl−CoAacetyl-CoA does not result in the permanent "fixing" of CO2CO_2.
  • Product Release: Fatty acids are typically released as FA−CoAFA-CoA when the chain length reaches C14C_{14} to C18C_{18}.
  • Desaturation:
    • The conversion of −CH2−CH2−-CH_2-CH_2- to −CH=CH−-CH=CH- (double bond introduction) occurs AFTER release from the enzyme.
    • Humans lack the enzymes to introduce double bonds beyond carbon 99.
    • Consequently, long, unsaturated omega-3 and omega-6 fatty acids are considered essential in the diet.

Esterification and Triglyceride Formation

  • Process: Joining 33 fatty acid chains to a glycerolglycerol backbone to form a triglyceride (neutral fat) and 33 water molecules (3H2O3 H_2O).
  • Substrate Specificity: The glycerol backbone must be in the form of glycerol−3−phosphateglycerol-3-phosphate.
  • Sources of Glycerol-3-P:
    • Liver: Can produce it directly from glycerol via the enzyme glycerolkinaseglycerol kinase (GYKGYK).
    • Other tissues (WAT): Must derive it from the reduction of glycolytic dihydroxyacetone−phosphatedihydroxyacetone-phosphate (DHAPDHAP).
    • Glyceroneogenesis: Synthesis from pyruvatepyruvate via PEPCK−CPEPCK-C, a pathway similar to gluconeogenesis that produces glycerol−3−Pglycerol-3-P from non-glucose precursors.
  • Enzyme Regulation: The esterification enzyme uses FA−CoAFA-CoA (not free fatty acids). Both the esterification enzyme and FAS are upregulated by insulin through gene expression and protein synthesis.
  • Inhibition: FAS expression is downregulated by high fat availability (e.g., a Western diet).

Mitochondrial Export: The Citrate Transport System

  • The Challenge: Acetyl−CoAAcetyl-CoA is produced in the mitochondrial matrix but lipogenesis occurs in the cytoplasm. Acetyl−CoAAcetyl-CoA cannot cross the membrane directly.
  • The Shuttle Mechanism:
    1. Acetyl−CoAAcetyl-CoA condenses with oxaloacetateoxaloacetate to form citratecitrate in the mitochondria.
    2. CitrateCitrate moves into the cytoplasm easily.
    3. ATP-Citrate Lyase (ACL): In the cytoplasm, this enzyme cleaves citratecitrate back into acetyl−CoAacetyl-CoA and oxaloacetateoxaloacetate.
    4. This cleavage reaction requires energy: ATP→ADP+PiATP \rightarrow ADP + P_i.
  • Inhibitor Case Study: Hydroxy-citrate (OHCitOHCit), found in the Brindle Berry, acts as an inhibitor of ACL and is sold as a fat synthesis inhibitor.
  • Maintaining the Pool: OxaloacetateOxaloacetate must return to the matrix to prevent depletion. Since it cannot cross the inner mitochondrial membrane alone, it is converted to malatemalate and then pyruvatepyruvate, which generates the "magic reductant" (NADPHNADPH) via malic enzyme.

Metabolic Signaling and Regulation by Malonyl-CoA

  • Citrate as a "Battery %": High cytoplasmic citrate indicates a high energy charge. It:
    • Switches OFF Beta-oxidation (via malonyl−CoAmalonyl-CoA).
    • Switches OFF Glycolysis.
    • Switches ON Fatty Acid Synthesis.
    • Switches ON Gluconeogenesis.
  • Malonyl-CoA and Beta-Oxidation Inhibition:
    • The transport of fatty acids into the mitochondrial matrix for degradation requires the carnitine system (CAT−ICAT-I).
    • Malonyl−CoAMalonyl-CoA (produced by ACC) inhibits CAT−ICAT-I.
    • Therefore, insulin-stimulated production of malonyl−CoAmalonyl-CoA effectively inhibits fatty acid oxidation (FAoxFAox).

The Pentose Phosphate Pathway (PPP): Reductant Support

  • Function: The PPP produces NADPHNADPH in proportion to the demand for lipogenesis.
  • NADPH vs. NADH: Chemically similar but bound by different enzymes; Dr. Clemson compares them to different "international currencies."
  • Regulatory Step: The key regulatory enzyme is Glucose-6-Phosphate Dehydrogenase (G6PDHG6PDH).
  • Reaction Phases:
    • Oxidative Phase: G6PG6P is oxidized to gluconolactone, producing NADPHNADPH. Further oxidation and decarboxylation yield more NADPHNADPH and a 5-carbon sugar, ribulose−5−phosphateribulose-5-phosphate.
    • Non-Oxidative Phase: Carbon atoms are rearranged to return the 5-carbon sugars back to glycolysis. Catalyzed by transaldolases and transketolases.
      • 5C+5C→C7+C35C + 5C \rightarrow C7 + C3 (Transketolase; 2C2C unit transfer).
      • C7+C3→C6+C4C7 + C3 \rightarrow C6 + C4 (Transaldolase; 3C3C unit transfer).
      • C4+C5→C6+C3C4 + C5 \rightarrow C6 + C3 (Transketolase; 2C2C unit transfer).
    • The resulting C6C6 and C3C3 sugars re-enter glycolysis.

Specialized Roles of the PPP and Clinical Relevance

  • Nucleotide Synthesis: Ribose−5−phosphateRibose-5-phosphate produced by the PPP is essential for DNA, RNA, and cofactor synthesis.
  • Antioxidant Role: NADPHNADPH is vital for maintaining cellular antioxidant defenses.
  • Clinical Anemia: Red blood cells (RBCs) are highly prone to oxidative damage. A deficiency in G6PDHG6PDH can cause anemia due to the inability to manage oxidative stress, leading to "Heinz bodies" (clumps of hemoglobin).

Integrated Regulatory Summary

  • G6PDH: Stimulated by the demand for NADP+NADP^+ (i.e., when NADPHNADPH is consumed by lipogenesis).
  • Insulin: Acts as a master regulator. Stimulates GLUT−4GLUT-4, PDHPDH, and ACCACC. It also activates genes for FASFAS and the esterification enzyme.
  • Krebs Cycle: Responds to the cell's demand for ATPATP.
  • Glycolysis: Provides the necessary glycerol−3−Pglycerol-3-P backbone and the acetyl−CoAacetyl-CoA substrate.